Rudolf A. de Boer

University Medical Center Groningen

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

6.7Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Age dependent associations of risk factors with heart failure: pooled population based cohort study

BMJ(2021)10.1136/bmj.n461

Top 3%

6.3DataRank

Top 3%232 citations

Samantha M. Paniagua, Emily S. Lau, Norrina B. Allen, Michael J. Blaha, Ron T. Gansevoort +12 more

Papers

Driven by 53 papers — median percentile 75. Top paper: “Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes”.

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

JAMA(2020)10.1001/jama.2020.1906

N/A

6.7DataRank · unranked

539 citations

Subodh Verma, Kieran F. Docherty, Silvio E. Inzucchi, Inder S. Anand, Jan Bělohlávek +34 more

Age dependent associations of risk factors with heart failure: pooled population based cohort study

BMJ(2021)10.1136/bmj.n461

Top 3%

6.3DataRank

Top 3%232 citations

Samantha M. Paniagua, Emily S. Lau, Norrina B. Allen, Michael J. Blaha, Ron T. Gansevoort +12 more

Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF

Circulation(2022)10.1161/circulationaha.121.058910

N/A

4.7DataRank · unranked

131 citations

Kieran F. Docherty, Hiddo J.L. Heerspink, Rudolf A. de Boer, Kevin Damman, Silvio E. Inzucchi +16 more

Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial

Circulation(2022)10.1161/circulationaha.122.061754

N/A

4.2DataRank · unranked

152 citations

Pardeep S. Jhund, Jan Bělohlávek, Rudolf A. de Boer, Chern‐En Chiang, Akshay S. Desai +22 more

Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2022)10.1001/jamacardio.2022.3750

N/A

2.9DataRank · unranked

67 citations

Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi +12 more

Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF

Diabetes Care(2020)10.2337/dc20-1675

N/A

2.7DataRank · unranked

76 citations

Kieran F. Docherty, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski +16 more

52 Genetic Loci Influencing Myocardial Mass

Journal of the American College of Cardiology(2016)10.1016/j.jacc.2016.07.729

N/A

2.4DataRank · unranked

135 citations

Jessica van Setten, Niek Verweij, Georg Vogler, Matthew T. Maurano, Xinchen Wang +172 more

Vitamin D Deficiency: Universal Risk Factor for Multifactorial Diseases?

Current Drug Targets(2011)10.2174/138945011793591590

N/A

2.1DataRank · unranked

40 citations

Rudolf A. de Boer, Ronald P. Stolk, Joris P.J. Slaets, Bruce H.R. Wolffenbuttel, Gerjan Navis +1 more

Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

Nature Medicine(2022)10.1038/s41591-022-02102-9

N/A

1.7DataRank · unranked

67 citations

James C. Fang, Akshay S. Desai, Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan +19 more

Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA‐HF

European Journal of Heart Failure(2020)10.1002/ejhf.2083

N/A

1.7DataRank · unranked

48 citations

Kieran F. Docherty, Olof Bengtsson, Rudolf A. de Boer, Akshay S. Desai, Jarosław Dróżdż +19 more

Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial

European Heart Journal(2023)10.1093/eurheartj/ehad283

N/A

1.6DataRank · unranked

56 citations

Muthiah Vaduganathan, Brian Claggett, Orly Vardeny, Akshay S. Desai, Pardeep S. Jhund +15 more

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER

Circulation(2022)10.1161/circulationaha.122.062832

N/A

1.5DataRank · unranked

56 citations

Muthiah Vaduganathan, Brian Claggett, Sheila M. Hegde, Maria Pabón, Ian J. Kulac +22 more

Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JACC Heart Failure(2022)10.1016/j.jchf.2022.08.007

N/A

1.5DataRank · unranked

50 citations

Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, Pardeep S. Jhund, Rudolf A. de Boer +13 more

Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation

Circulation Genomic and Precision Medicine(2020)10.1161/circgen.119.002874

N/A

1.4DataRank · unranked

30 citations

Amelia Weber Hall, Seung Hoan Choi, Sean J. Jurgens, Jeffrey Haessler, Nathan A. Bihlmeyer +55 more

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine(2019)10.1056/nejmoa1911303

N/A

1.3DataRank · unranked

5622 citations

Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod, Felipe A. Martinez +43 more

Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial

Circulation(2023)10.1161/circulationaha.123.066506

N/A

1.3DataRank · unranked

36 citations

Muthiah Vaduganathan, Brian Claggett, Jonathan W. Cunningham, Kieran F. Docherty, Akshay S. Desai +13 more

Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial

The Lancet Diabetes & Endocrinology(2022)10.1016/s2213-8587(22)00308-4

N/A

1.2DataRank · unranked

41 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer +14 more

Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2023)10.1001/jamacardio.2023.4664

N/A

1.0DataRank · unranked

38 citations

Brian Claggett, Muthiah Vaduganathan, Akshay S. Desai, Pardeep S. Jhund, Orly Vardeny +17 more

Effect of Dapagliflozin on Health Status and Quality of Life Across the Spectrum of Ejection Fraction: Participant-Level Pooled Analysis from the DAPA-HF and DELIVER Trials

European Journal of Heart Failure(2023)10.1002/ejhf.2909

N/A

1.0DataRank · unranked

22 citations

Mikhail Kosiborod, Muthiah Vaduganathan, Brian Claggett, Zi Michael Miao, Ian J. Kulac +13 more

Heart Failure, Chronic Obstructive Pulmonary Disease and Efficacy and Safety of Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from DELIVER

European Journal of Heart Failure(2023)10.1002/ejhf.3000

N/A

0.889DataRank · unranked

26 citations

Henri Lu, Toru Kondo, Erasmus Bachus, Rudolf A. de Boer, Silvio E. Inzucchi +8 more

Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial

Circulation(2023)10.1161/circulationaha.123.065254

N/A

0.805DataRank · unranked

21 citations

Muthiah Vaduganathan, Senthil Selvaraj, Brian Claggett, Zi Michael Miao, Akshay S. Desai +13 more

Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2020.07.044

N/A

0.701DataRank · unranked

106 citations

Emily S. Lau, Michael J. Blaha, Samantha M. Paniagua, Martin G. Larson, Bruce M. Psaty +25 more

Impact of COVID-19 in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Enrolled in the DELIVER Trial

European Journal of Heart Failure(2023)10.1002/ejhf.3043

N/A

0.691DataRank · unranked

16 citations

Mikhail Kosiborod, Brian Claggett, Zi Michael Miao, Muthiah Vaduganathan, Carolyn S.P. Lam +19 more

Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

JAMA Cardiology(2023)10.1001/jamacardio.2023.1342

N/A

0.671DataRank · unranked

13 citations

Alvin Chandra, Mikhail Kosiborod, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund +17 more

Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial

Circulation(2023)10.1161/circulationaha.122.062918

N/A

0.405DataRank · unranked

7 citations

Karola Jering, C. Jan Willem Borleffs, Rudolf A. de Boer, Brian Claggett, Akshay S. Desai +15 more

Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis

British Journal of Cancer(2025)10.1038/s41416-025-03140-z

Top 46%

0.395DataRank

Top 46%11 citations

Aditya Surapaneni, Yingying Sang, Josef Coresh, Morgan E. Grams, Kunihiro Matsushita +94 more

Priorities in Cardio-Oncology Basic and Translational Science

JACC CardioOncology(2023)10.1016/j.jaccao.2023.08.003

N/A

0DataRank · unranked

43 citations

Carlo G. Tocchetti, Pietro Ameri, Hossein Ardehali, Aarti Asnani, Rudolf A. de Boer +33 more

Association of Initial and Longitudinal Changes in C-reactive Protein With the Risk of Cardiovascular Disease, Cancer, and Mortality

Mayo Clinic Proceedings(2023)10.1016/j.mayocp.2022.10.013

N/A

0DataRank · unranked

41 citations

Dongyu Wang, Joseph Pierre Aboumsallem, Canxia Shi, Sanne de Wit, Elizabeth Liu +14 more

Dynamic loading of human engineered heart tissue enhances contractile function and drives a desmosome-linked disease phenotype

Science Translational Medicine(2021)10.1126/scitranslmed.abd1817

N/A

0DataRank · unranked

125 citations

M. Vermeer, Rebecca Duffy, Ivan Batalov, Duco Kramer, Joshua W. Tashman +18 more

Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect

Nature Genetics(2021)10.1038/s41588-020-00762-2

N/A

0DataRank · unranked

296 citations

Catherine Francis, Xiao Yun Xu, Alexa M.C. Vermeer, Andrew R. Harper, Roy Huurman +65 more

Fighting HFpEF in women: taking aim at belly fat

European Heart Journal(2020)10.1093/eurheartj/ehaa952

N/A

0DataRank · unranked

9 citations

Laura M G Meems, Rudolf A. de Boer, Coenraad Withaar

Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure

Circulation Heart Failure(2020)10.1161/circheartfailure.120.007684

N/A

0DataRank · unranked

145 citations

Timothy Matsuura, Herman H.W. Silljé, Kirsten T. Nijholt, Kendra S. McDaid, Swapnil V. Shewale +8 more

Urinary albumin excretion and cancer risk: the PREVEND cohort study

Nephrology Dialysis Transplantation(2023)10.1093/ndt/gfad107

N/A

0DataRank · unranked

15 citations

Lyanne M. Kieneker, Bert van der Vegt, Stephan J. L. Bakker, Eke G. Gruppen, Niek F. Casteleijn +7 more

Multiple Prior Live Births Are Associated With Cardiac Remodeling and Heart Failure Risk in Women

Journal of Cardiac Failure(2023)10.1016/j.cardfail.2022.12.014

N/A

0DataRank · unranked

10 citations

Samantha M. Paniagua, Emily S. Lau, Dongyu Wang, Elizabeth Liu, Martin G. Larson +18 more

Mediators of the association between albuminuria and incident cancer: the PREVEND study

Clinical Kidney Journal(2023)10.1093/ckj/sfad295

N/A

0DataRank · unranked

2 citations

Priya Vart, Lyanne M. Kieneker, Bert van der Vegt, Stephan J. L. Bakker, Eke G. Gruppen +7 more

Large scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy

medRxiv(2023)10.1101/2023.01.28.23285147

N/A

0DataRank · unranked

12 citations

Sean Zheng, Christopher Grace, Paloma Jordà, Catherine Francis, Sean J. Jurgens +57 more

Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence

European Heart Journal(2024)10.1093/eurheartj/ehae105

N/A

0DataRank · unranked

36 citations

Ágnes Paál, Pietro Ameri, Wouter C. Meijers, Giorgio Minotti, Ioanna Andreadou +15 more

Reassessing the Mechanisms of PLN-R14del Cardiomyopathy

JACC Basic to Translational Science(2024)10.1016/j.jacbts.2024.02.017

N/A

0DataRank · unranked

24 citations

Rudolf A. de Boer, Catherine A. Makarewich, Peter van der Meer, Herman H.W. Silljé, Nienke M. Stege

Beta-Blocker Use and Outcomes in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3383

N/A

0DataRank · unranked

18 citations

Alasdair D Henderson, Li Shen, Toru Kondo, Mingming Yang, Ross T. Campbell +17 more

Dapagliflozin and Quality of Life Measured Using the EuroQol 5-Dimension Questionnaire in Patients with Heart Failure with Reduced and Mildly Reduced/Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3263

N/A

0DataRank · unranked

14 citations

Toru Kondo, Atefeh Talebi, Pardeep S. Jhund, Kieran F. Docherty, Brian Claggett +15 more

Dapagliflozin in Patients with Heart Failure and Previous Myocardial Infarction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER

European Journal of Heart Failure(2024)10.1002/ejhf.3184

N/A

0DataRank · unranked

11 citations

Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Alberto Foà, Akshay S. Desai +17 more

Sodium-glucose co-transporter 2 inhibitors and new-onset diabetes in cardiovascular or kidney disease

European Heart Journal(2024)10.1093/eurheartj/ehae780

N/A

0DataRank · unranked

8 citations

Mats Christian Højbjerg Lassen, Brian Claggett, Zi Michael Miao, Silvio E. Inzucchi, Kieran F. Docherty +16 more

Exploring Cardiac Fibrosis

Automática e instrumentación(2024)10.1016/j.jacbts.2024.06.006

N/A

0DataRank · unranked

0 citations

Reza Ardehali, Rudolf A. de Boer

Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy

Nature Genetics(2025)10.1038/s41588-025-02087-4

N/A

0DataRank · unranked

55 citations

Sean L. Zheng, Christopher Grace, Paloma Jordà, Catherine Francis, Dominique M West +95 more

Update on Preclinical Models of Cancer Therapy-Related Cardiac Dysfunction: Challenges and Perspectives. A Scientific Statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart

European Journal of Heart Failure(2025)10.1002/ejhf.3636

N/A

0DataRank · unranked

12 citations

Pietro Ameri, Aarti Asnani, Edoardo Bertero, Rudolf A. de Boer, Dimitrios Farmakis +18 more

Natriuretic Peptide Cut Points for Heart Failure Classification in Individuals With and Without Obesity

Circulation Heart Failure(2025)10.1161/circheartfailure.125.013112

N/A

0DataRank · unranked

2 citations

Juhi K. Parekh, Leah Kosyakovsky, Sophie M. Nemeth, Emily S. Lau, James L. Januzzi +14 more

Ketone bodies and cancer risk in the general population: The prevention of renal and vascular end‐stage disease (PREVEND) study

European Journal of Clinical Investigation(2025)10.1111/eci.70100

N/A

0DataRank · unranked

0 citations

Martine Knol, Lyanne M. Kieneker, Bert van der Vegt, Stephan J. L. Bakker, Eke G. Gruppen +6 more

Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer

Nature Reviews Cardiology(2022)10.1038/s41569-022-00698-6

N/A

0DataRank · unranked

125 citations

Javid J. Moslehi, Rudolf A. de Boer, Anja Karlstaedt

Albuminuria is associated with increased risk of dementia, independent of eGFR: The SCREAM project

Journal of Internal Medicine(2025)10.1111/joim.70022

N/A

0DataRank · unranked

0 citations

Ron T. Gansevoort, Lyanne M. Kieneker, Yuanhang Yang, Alessandro Bosi, Rudolf A. de Boer +5 more

SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

The Lancet(2022)10.1016/s0140-6736(22)01429-5

N/A

0DataRank · unranked

930 citations

Kieran F. Docherty, Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez +9 more

Cardiovascular disease related circulating biomarkers and cancer incidence and mortality: is there an association?

Cardiovascular Research(2021)10.1093/cvr/cvab282

N/A

0DataRank · unranked

32 citations

Elizabeth Liu, Samantha M. Paniagua, Emily S. Lau, Shawn X. Li, Katherine S. Takvorian +13 more

Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartan

European Journal of Heart Failure(2022)10.1002/ejhf.2722

N/A

0DataRank · unranked

34 citations

Jawad H. Butt, Toru Kondo, Karola Jering, Kieran F. Docherty, Pardeep S. Jhund +16 more

Reverse cardio-oncology: Exploring the effects of cardiovascular disease on cancer pathogenesis

Journal of Molecular and Cellular Cardiology(2021)10.1016/j.yjmcc.2021.09.008

N/A

0DataRank · unranked

73 citations

Joseph Pierre Aboumsallem, Kathryn J. Moore, Rudolf A. de Boer, Graeme J. Koelwyn

Rudolf A. de Boer

Indexed papers

Top data-sharing exemplar

Papers